- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 138.24M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $137.29M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $119.66M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $263.91M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $248.43M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $932.21M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.04B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.31B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.4B |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $0 |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $59K |
| Revenue | Q1 2025 · Mar 31, 2025 | $3.03M |
| Revenue | Q1 2025 · Mar 31, 2024 | $56.38M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $222.95M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $160.71M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 135.28M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.87M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$109.39M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.55B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.59B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.48 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.48 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $36.32M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $100.13M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$65.28M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$80.08M |